Automating Knowledge Discovery
IOMICS’s FUSION Analytics Platform™ is a fully automated cognitive computing system and discovery service used by leading academic and commercial scientists to perform advanced desktop science. FUSION provides multi-scale biochemical data management, on-demand high-performance computing, data-driven predictive model development, integrated informatics, advanced network sciences and actionable evidence reports—all seamlessly integrated in an award-winning interactive environment.
Contact us today to learn how FUSION’s advanced analytics can provide unique insights into biochemical and molecular activities, drive critical research initiatives and accelerate discovery. At IOMICS, we believe in the power of AI to change our world.
Accelerating Science
FUSION for Chemical Engineering
Chemical engineers play a critical role in both drug discovery and production operations. To improve progress, the industry must embrace new modeling and statistical tools capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiscale heterogeneous data types to model and characterize chemical and environmental activity, and to predict potential toxicity and other behaviors of interest in production compounds.
FUSION can be live linked with chemical assays, production instrumentation, and environmental sensors, which enables a new class of real-time analysis and control. This permits identification of hidden chemical hazards, promotes safer production processes and accelerates new product research. The computational strategies utilized within the FUSION Analytics Platform can guide green chemical design, safer food production and more effective bioremediation practices.
Chemical Intelligence. We can make it happen for you.™
Chemical engineers can now rapidly build and validate predictive models that test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile chemical and process behavior in novel ways. FUSION predictive models, integrated informatics and advanced network sciences will drive accelerated analysis and hyperspeed collaboration among remote team members.
FUSION for Pharmaceutical Research
The pace and complexity of pharmaceutical research is rapidly increasing. The industry has become data rich, yet obtaining actionable drug development and biomarker discovery information remains a challenge. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiscale heterogeneous data types to model and characterize highly dynamic molecular processes and reduce product attrition rates.
FUSION can even be live linked with NGS technologies and high-complexity screening which enables a new class of real-time analysis. This accelerates the identification of druggable properties and privileged structures, optimal scaffold design and ADMET profiling throughout the drug discovery and clinical trials process. The computational strategies utilized within the FUSION Analytics Platform can help provide critical new insights about whether you have the right target, the right hit and the right exposure earlier in the process.
Molecular Intelligence. We can make it happen for you.™
Chemists and biologists can now rapidly build and validate predictive models that test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile molecular behavior in novel ways. FUSION predictive models, integrated informatics and advanced network sciences will drive accelerated analysis and hyperspeed collaboration among remote team members.
FUSION for Clinical Care
The pace and complexity of healthcare is rapidly increasing. Medicine has now entered its data age with context-sensitive EHR/HIE systems, high-complexity assays, wearable body sensors, mobile technologies and telemedicine, and a broad range of online patient/caregiver forums and information resources. As a result, it is now possible to capture vast amounts of information about our individual and shared biology as well as the environment around us. The sum of this information will transform medicine, turning a field aimed at treating the average patient into one that will soon customize treatment to the individual.
To cost-effectively develop and deploy personalized medicine strategies and new wellness programs, we need more powerful analytics capable of extracting important signals within high-complexity assays and across multiple data types. The FUSION Analytics Platform™ is designed to stratify patient populations and extract actionable information for clinical use within high-fidelity point-of-care models. Healthcare workers can use deployed FUSION models to improve patient outcomes, reduce costs, and forge stronger value-added linkages between the institution and the patient.
Clinical Intelligence. We can make it happen for you.™
Healthcare workers can now rapidly build and validate patient and disease models to test intervention effectiveness both in silico and in the clinic. FUSION cuts complex patient model development time from months to weeks allowing you to profile patient, disease, and drug behavior in novel ways. FUSION models will permit rapid in silico based patient profiling and intervention prioritization to support real-time coordinated care between institutions, healthcare workers, patients, and caregivers.
Automating Knowledge Discovery
IOMICS’s FUSION Analytics Platform™ is a fully automated cognitive computing system and discovery service used by leading academic and commercial scientists to perform advanced desktop science. FUSION provides multi-scale biochemical data management, on-demand high-performance computing, data-driven predictive model development, integrated informatics, advanced network sciences and actionable evidence reports—all seamlessly integrated in an award-winning interactive environment.
Contact us today to learn how FUSION’s advanced analytics can provide unique insights into biochemical and molecular activities, drive critical research initiatives and accelerate discovery. At IOMICS, we believe in the power of AI to change our world.
Accelerating Science
FUSION for Chemical Engineering
Chemical engineers play a critical role in both drug discovery and production operations. To improve progress, the industry must embrace new modeling and statistical tools capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiscale heterogeneous data types to model and characterize chemical and environmental activity, and to predict potential toxicity and other behaviors of interest in production compounds.
FUSION can be live linked with chemical assays, production instrumentation, and environmental sensors, which enables a new class of real-time analysis and control. This permits identification of hidden chemical hazards, promotes safer production processes and accelerates new product research. The computational strategies utilized within the FUSION Analytics Platform can guide green chemical design, safer food production and more effective bioremediation practices.
Chemical Intelligence. We can make it happen for you.™
Chemical engineers can now rapidly build and validate predictive models that test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile chemical and process behavior in novel ways. FUSION predictive models, integrated informatics and advanced network sciences will drive accelerated analysis and hyperspeed collaboration among remote team members.
FUSION for Pharmaceutical Research
The pace and complexity of pharmaceutical research is rapidly increasing. The industry has become data rich, yet obtaining actionable drug development and biomarker discovery information remains a challenge. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiscale heterogeneous data types to model and characterize highly dynamic molecular processes and reduce product attrition rates.
FUSION can even be live linked with NGS technologies and high-complexity screening which enables a new class of real-time analysis. This accelerates the identification of druggable properties and privileged structures, optimal scaffold design and ADMET profiling throughout the drug discovery and clinical trials process. The computational strategies utilized within the FUSION Analytics Platform can help provide critical new insights about whether you have the right target, the right hit and the right exposure earlier in the process.
Molecular Intelligence. We can make it happen for you.™
Chemists and biologists can now rapidly build and validate predictive models that test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile molecular behavior in novel ways. FUSION predictive models, integrated informatics and advanced network sciences will drive accelerated analysis and hyperspeed collaboration among remote team members.
FUSION for Clinical Care
The pace and complexity of healthcare is rapidly increasing. Medicine has now entered its data age with context-sensitive EHR/HIE systems, high-complexity assays, wearable body sensors, mobile technologies and telemedicine, and a broad range of online patient/caregiver forums and information resources. As a result, it is now possible to capture vast amounts of information about our individual and shared biology as well as the environment around us. The sum of this information will transform medicine, turning a field aimed at treating the average patient into one that will soon customize treatment to the individual.
To cost-effectively develop and deploy personalized medicine strategies and new wellness programs, we need more powerful analytics capable of extracting important signals within high-complexity assays and across multiple data types. The FUSION Analytics Platform™ is designed to stratify patient populations and extract actionable information for clinical use within high-fidelity point-of-care models. Healthcare workers can use deployed FUSION models to improve patient outcomes, reduce costs, and forge stronger value-added linkages between the institution and the patient.
Clinical Intelligence. We can make it happen for you.™
Healthcare workers can now rapidly build and validate patient and disease models to test intervention effectiveness both in silico and in the clinic. FUSION cuts complex patient model development time from months to weeks allowing you to profile patient, disease, and drug behavior in novel ways. FUSION models will permit rapid in silico based patient profiling and intervention prioritization to support real-time coordinated care between institutions, healthcare workers, patients, and caregivers.
ASPEN™ is a feature-rich in silico model building and hypothesis discovery service that allows you to perform real-time specification-based data staging and predictive model development for a broad range of chemical characterization, biomarker discovery, and drug development initiatives. ASPEN is the only solution that seamlessly combines chemical and molecular data staging, predictive model creation, validation, and performance reporting, along with realtime pathway analysis and automated evidence summaries, all in one integrated service. ASPEN users can start the accelerated discovery process by querying our semantically integrated knowledgebase with contents from hundreds of open access chemical and molecular sources, or by using IOMICS SmartETL™ technology to rapidly upload laboratory results to ASPEN’s virtual machine environment that ensures full isolation, security and privacy for each experiment and study. For high-throughput experiments, ASPEN also provides options for linking with NGS technologies, high-complexity assays, and digital instrumentation for both automated and continuous analysis and process characterization. ASPEN is accelerating scientific discovery by eliminating the major scientific and operational barriers to developing and using high-quality data-driven computational models in your research.
